We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
18 hedge funds and large institutions have $2.14M invested in Interpace Biosciences, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
41% more capital invested
Capital invested by funds: $1.52M → $2.14M (+$625K)
29% more funds holding
Funds holding: 14 → 18 (+4)
Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.29M |
| 2 |
MFG
Magnus Financial Group
New York
|
+$220K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$157K |
| 4 |
Squarepoint
New York
|
+$114K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$58.3K |
